搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
The American Conservative
6 分钟
Will RFK Kibosh Ozempic?
Should he make it through the nomination process, Kennedy plans to follow Trump’s mandate to remove “corruption” from HHS-led ...
BioSpace
28 分钟
Novo’s Wegovy Launched in China at a Fraction of US Price
Wegovy is being made available to Chinese patients five months after its approval in the country. Novo will sell the medicine ...
STAT
38 分钟
Pharmalittle: We’re reading about RFK Jr. and vaccines, obesity-drug prescribing for kids ...
Robert F. Kennedy Jr. would have broad power as HHS secretary to strip vaccine makers' protections against lawsuits ...
1 小时
on MSN
Novo Nordisk launches obesity drug Wegovy in China
Novo Nordisk said on Monday it has launched its popular obesity drug Wegovy in China, the world's second-largest ...
2 小时
on MSN
Novo Nordisk has launched obesity drug Wegovy in China
Novo Nordisk said on Monday it has launched its popular obesity drug Wegovy in China, the world's second-largest ...
bnnbloomberg
3 小时
Novo Nordisk Launches Wegovy in China With Prices Well Below US
(Bloomberg) -- Novo Nordisk A/S is launching its top-selling Wegovy obesity drug in China at a fraction of the US price, a ...
3 小时
What RFK Jr. Has Said About Ozempic the Popular Weight Loss Drug
Kennedy Jr., who has been tapped by Trump to lead the HHS, has been critical of Ozempic and other weight loss drugs.
3 小时
Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key ...
Hims & Hers Health, Inc. (“Hims & Hers”) (NYSE: HIMS), the leading health and wellness platform, today announced Deb Autor, ...
pharmaphorum
4 小时
Tirzepatide gets a big win in obesity-related heart failure
"Obesity contributes to worsening heart failure, and while tirzepatide causes considerable weight loss, research is lacking ...
4 小时
Medicaid fuels US coverage of Novo, Lilly weight-loss drugs
State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access to Novo Nordisk's Wegovy or Eli Lilly's Zepbound, according to the AXIACI ...
policymed.com
5 小时
FTC Sues PBMs and GPOs For Anti-Competitive Rebate Practice
The United States Federal Trade Commission (FTC) filed an administrative complaint against the nation’s three largest ...
5 小时
Eli Lilly and Novo want to shake off Ozempic copycats. Are they ready to meet demand?
The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈